This bulletin includes guidance on the safe prescribing and monitoring of medicines used for gender dysphoria in adults, young people, and children. It reviews hormone treatments, shared care prescribing protocols, safety considerations, and medicine cost comparisons. Implementation tools include shared care guideline templates, audit on puberty blockers, puberty suppressing dispensing checklist, flowchart for gender dysphoria treatment and presentation.
